GSK Plc is trading at 28.14 as of the 8th of February 2026. This is a 4.12 percent decrease since the beginning of the trading day. The stock's lowest day price was 28.14. GSK Plc has about a 32 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 10th of November 2025 and ending today, the 8th of February 2026. Click here to learn more.
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. The company has 4.09 B outstanding shares. More on GSK plc
GSK plc [GLAXF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Large-Cap' category with a current market capitalization of 73.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GSK Plc's market, we take the total number of its shares issued and multiply it by GSK Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. GSK plc classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 4.09 B outstanding shares.
GSK plc has accumulated about 6.53 B in cash with 7.4 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.62.
Check GSK Plc Probability Of BankruptcyOwnership AllocationGSK plc has a total of 4.09 Billion outstanding shares. 30% of GSK plc outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Therefore, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check GSK Ownership Details
About 41.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.11. GSK plc last dividend was issued on the 23rd of February 2023. The entity had 4:5 split on the 19th of July 2022. GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Glaxosmithkline Plc is traded on OTC Exchange in the United States.The quote for GSK plc is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about GSK plc call the company at 44 20 8047 5000 or check out https://www.gsk.com.
GSK plc Investment Alerts
GSK plc had very high historical volatility over the last 90 days
The company currently falls under 'Large-Cap' category with a current market capitalization of 73.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GSK Plc's market, we take the total number of its shares issued and multiply it by GSK Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
GSK Profitablity
The company has Profit Margin (PM) of 0.51 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25.
Technical Drivers
As of the 8th of February, GSK Plc retains the Market Risk Adjusted Performance of (0.78), risk adjusted performance of 0.0967, and Semi Deviation of 2.72. GSK Plc technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out GSK plcinformation ratio, as well as the relationship between the value at risk and expected short fall to decide if GSK Plc is priced correctly, providing market reflects its last-minute price of 28.14 per share. Given that GSK plc has jensen alpha of 0.4096, we strongly advise you to confirm GSK plc's regular market performance to make sure the company can sustain itself at some point in the future.
The output start index for this execution was zero with a total number of output elements of sixty-one. GSK plc Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe GSK Plc price patterns.
GSK Plc Outstanding Bonds
GSK Plc issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. GSK plc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most GSK bonds can be classified according to their maturity, which is the date when GSK plc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
GSK Plc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GSK Plc pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
GSK Plc's time-series forecasting models are one of many GSK Plc's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary GSK Plc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in GSK Plc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Portfolio Comparator Now
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
GSK Plc financial ratios help investors to determine whether GSK Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GSK with respect to the benefits of owning GSK Plc security.